Literature DB >> 12773615

Redirection of B cell responsiveness by transforming growth factor beta receptor.

Jurgen Roes1, B Ken Choi, Balthazar B Cazac.   

Abstract

The multifunctional transforming growth factor beta receptor (TbetaR) ligand pair plays a central role in the regulation of lymphocyte homeostasis and prevention of autoimmunity. Although the mechanisms underlying the induction of transcriptional modulators by TbetaR have been studied in considerable detail, relatively little is known about the regulatory pathways targeted. To shed light on the mechanisms involved in negative regulation of B cell responses we identified TbetaR-dependent transcriptome changes by comparative gene expression profiling of normal and TbetaR-deficient primary B cells. The data reveal TbetaR-mediated induction of inhibitors of antigen receptor signaling (Ship-1, CD72) as well as inhibitors of the Jak/Stat pathway and signaling by means of Toll-like receptors (SOCS1,3). These inhibitory effects are complemented by induction of antiproliferative transcription factors. In contrast to this inhibition, G protein-coupled receptors such as CXCR4 and agonists mediating Ca2+ flux (inositol trisphosphate receptor subtype 2) are induced by TbetaR, indicating enhancement of the Ca2+ storage/ release system and chemotactic responses. Suppression of proapoptotic genes suggests support of cell survival. Confirming the shift in B cell responsiveness, antigen-receptor-mediated activation of Syk and phospholipase C-gamma2, as well as Stat6 phosphorylation, is inhibited, whereas chemotaxis, Ca2+ release, and cell survival are enhanced in transforming growth factor-beta-sensitive B cells. The data provide a molecular basis for TbetaR-mediated inhibition of B cell responsiveness and indicate that TbetaR maintains homeostasis not only through inhibition of the cell cycle but also by delivering a coherent instructive signal that redirects responsiveness to microenvironmental cues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773615      PMCID: PMC165860          DOI: 10.1073/pnas.0731875100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Regulation of B-cell fate by antigen-receptor signals.

Authors:  Hiroaki Niiro; Edward A Clark
Journal:  Nat Rev Immunol       Date:  2002-12       Impact factor: 53.106

2.  Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.

Authors:  R C Rickert; K Rajewsky; J Roes
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

Review 3.  Clonal selection and learning in the antibody system.

Authors:  K Rajewsky
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

4.  Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling.

Authors:  M Ono; H Okada; S Bolland; S Yanagi; T Kurosaki; J V Ravetch
Journal:  Cell       Date:  1997-07-25       Impact factor: 41.582

5.  Transforming growth factor beta 1 has differential effects on B cell proliferation and activation antigen expression.

Authors:  D Cross; J C Cambier
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

6.  SOCS1/JAB is a negative regulator of LPS-induced macrophage activation.

Authors:  Ichiko Kinjyo; Toshikatsu Hanada; Kyoko Inagaki-Ohara; Hiroyuki Mori; Daisuke Aki; Masanobu Ohishi; Hiroki Yoshida; Masato Kubo; Akihiko Yoshimura
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

7.  Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta.

Authors:  B L Kee; R R Rivera; C Murre
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

8.  Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.

Authors:  T B Barrett; G L Shu; K E Draves; A Pezzutto; E A Clark
Journal:  Eur J Immunol       Date:  1990-05       Impact factor: 5.532

9.  TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha.

Authors:  M Arsura; M Wu; G E Sonenshein
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

10.  Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP.

Authors:  Hector Valderrama-Carvajal; Eftihia Cocolakis; Annie Lacerte; Eun-Hye Lee; Gerald Krystal; Suhad Ali; Jean-Jacques Lebrun
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

View more
  17 in total

Review 1.  Inositol trisphosphate receptor Ca2+ release channels.

Authors:  J Kevin Foskett; Carl White; King-Ho Cheung; Don-On Daniel Mak
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

Review 2.  TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota.

Authors:  Sozaburo Ihara; Yoshihiro Hirata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2017-05-22       Impact factor: 7.527

Review 3.  Genetic evidence for the role of transforming growth factor-β in atopic phenotypes.

Authors:  Katherine A Weissler; Pamela A Frischmeyer-Guerrerio
Journal:  Curr Opin Immunol       Date:  2019-06-01       Impact factor: 7.486

4.  Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.

Authors:  Kaoru Morita; Tomohisa Okamura; Mariko Inoue; Toshihiko Komai; Shuzo Teruya; Yukiko Iwasaki; Shuji Sumitomo; Hirofumi Shoda; Kazuhiko Yamamoto; Keishi Fujio
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-30       Impact factor: 11.205

5.  Macrophage secretome from women with HIV-associated neurocognitive disorders.

Authors:  Krystal Colon; Juliana Perez-Laspiur; Raymond Quiles; Yolanda Rodriguez; Valerie Wojna; Scott A Shaffer; John Leszyk; Richard L Skolasky; Loyda M Melendez
Journal:  Proteomics Clin Appl       Date:  2015-11-18       Impact factor: 3.494

Review 6.  Therapeutic potential of regulatory cytokines that target B cells.

Authors:  Keishi Fujio; Tomohisa Okamura; Shuji Sumitomo; Kazuhiko Yamamoto
Journal:  Int Immunol       Date:  2015-12-08       Impact factor: 4.823

7.  B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex.

Authors:  Caroline H Wallace; Bill X Wu; Mohammad Salem; Ephraim A Ansa-Addo; Alessandra Metelli; Shaoli Sun; Gary Gilkeson; Mark J Shlomchik; Bei Liu; Zihai Li
Journal:  JCI Insight       Date:  2018-04-05

8.  SHIP-1 Couples to the Dectin-1 hemITAM and Selectively Modulates Reactive Oxygen Species Production in Dendritic Cells in Response to Candida albicans.

Authors:  Noelia Blanco-Menéndez; Carlos Del Fresno; Sandra Fernandes; Enrique Calvo; Ruth Conde-Garrosa; William G Kerr; David Sancho
Journal:  J Immunol       Date:  2015-09-28       Impact factor: 5.422

9.  Aberrant B Cell Receptor Signaling in Naïve B Cells from Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Stefan F H Neys; Peter Heukels; Jennifer A C van Hulst; Jasper Rip; Marlies S Wijsenbeek; Rudi W Hendriks; Odilia B J Corneth
Journal:  Cells       Date:  2021-05-26       Impact factor: 6.600

10.  Sec13 Regulates Expression of Specific Immune Factors Involved in Inflammation In Vivo.

Authors:  Thais G Moreira; Liang Zhang; Lihi Shaulov; Amnon Harel; Sharon K Kuss; Jessica Williams; John Shelton; Bandarigoda Somatilaka; Joachim Seemann; Jue Yang; Ramanavelan Sakthivel; Daniel R Nussenzveig; Ana M C Faria; Beatriz M A Fontoura
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.